Skip to content

CROI: ARV provision in Africa could cut HIV transmission by 90 per cent

Maraviroc to be developed as a microbicide

WHO expert panel wants fewer second-line ART choices

Patients who start anti-HIV treatment with a low CD4 cell count have a good chance of an undetectable viral load

Insulin resistance means a poorer response to anti-HCV therapy in HIV/HCV coinfected patients

Kaletra monotherapy studies yield conflicting results

Key European committee gives the nod to new Kaletra tablet for kids

Less risk of AIDS for patients with low CD4 cell count and no treatment options who stay on failing therapy

Raltegravir now available for UK patients